Lentivirus-mediated gene transfer to the rat, ovine and human cornea

Gene Therapy

Volumn 14, Issue 9, 2007, Pages 760-767

  Parker, D G A ^a   Kaufmann, C ^a   Brereton, H M ^a   Anson, D S ^b   Francis Staite, L ^a   Jessup, C F ^a   Marshall, K ^a   Tan, C ^b   Koldej, R ^b   Coster, D J ^a   Williams, K A ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

Corneal endothelium; Corneal transplantation; Lentiviral vector

Indexed keywords

LENTIVIRUS VECTOR; PHOSPHOGLYCERATE KINASE; YELLOW FLUORESCENT PROTEIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA ENDOTHELIUM; CORNEA TRANSPLANTATION; ENDOTHELIUM CELL; EX VIVO STUDY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE TRANSFER; GENETIC STABILITY; GENETIC TRANSDUCTION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REPORTER GENE; SARCOMA VIRUS; SHEEP; SIMIAN VIRUS 40; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CORNEAL DISEASES; CORNEAL TRANSPLANTATION; ENDOTHELIUM, CORNEAL; GENE EXPRESSION; GENE THERAPY; GENES, REPORTER; HIV-1; HUMANS; LUMINESCENT PROTEINS; MICROSCOPY, FLUORESCENCE; RATS; SHEEP; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSGENES; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC;

LENTIVIRUS; MYELOPROLIFERATIVE SARCOMA VIRUS; OVIS; OVIS ARIES; RATTUS; SIMIAE;

EID: 34247157817     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302921     Document Type: Article

References (48)

1. Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: A global perspective. Bull World Health Organ 2001; 79: 214-221.
2. Williams KA, Esterman AJ, Bartlett C, Holland H, Hornsby NB, Coster DJ, on behalf of all contributors to the Australian Corneal Graft Registry. How effective is corneal transplantation? Factors influencing long-term outcome in multivariate analysis. Transplantation 2006; 81: 896-901.
3. George AJ, Arancibia-Carcamo CV, Awad HM, Comer RM, Fehevari Z, King WJ et al. Gene delivery to the corneal endothelium. Am J Respir Crit Care Med 2000; 162: S194-S200.
4. Williams KA, Jessup CF, Coster DJ. Gene therapy approaches to prolonging corneal allograft survival. Expert Opin Biol Ther 2004; 4: 1059-1071.
5. Klebe S, Sykes PJ, Coster DJ, Krishnan R, Williams KA. Prolongation of sheep corneal allograft survival by transfer of the gene encoding ovine interleukin 10. Transplantation 2001; 71: 1214-1220.
6. Klebe S, Coster DJ, Sykes PJ, Swinburne S, Hallsworth P, Scheerlinck J-PY et al. Prolongation of sheep corneal allograft survival by transfer of the gene encoding ovine interleukin 12-p40 but not interleukin 4 to donor corneal endothelium. J Immunol 2005; 175 2219-2226.
7. Konig Merediz SA, Zhang EP, Wittig B, Hoffmann F. Ballistic transfer of minimalistic immunologically defined expression constructs for IL4 and CTLA4 into the corneal epithelium in mice after orthotopic corneal allograft transplantation. Graefes Arch Clin Exp Ophthalmol 2000; 238: 701-707.
8. Zhang EP, Franke J, Schroff M, Junghans C, Wittig B, Hoffmann F. Ballistic CTLA4 and IL-4 gene transfer into the lower lid prolongs orthotopic corneal graft survival in mice. Graefes Arch Clin Exp Ophthalmol 2003; 241: 921-926.
9. Pleyer U, Bertelmann E, Rieck P, Hartmann C, Volk HD, Ritter T. Survival of corneal allografts following adenovirus-mediated gene transfer of interleukin-4. Graefes Arch Clin Exp Ophthalmol 2002; 238: 531-536.
10. Rayner SA, Larkin DF, George AJ. TNF receptor secretion after ex vivo adenoviral gene transfer to cornea and effect on in vivo graft survival. Invest Ophthalmol Vis Sci 2001; 42: 1568-1573.
11. Murthy RC, McFarland TJ, Yoken J, Chen S, Barone C, Burke D et al. Corneal transduction to inhibit angiogenesis and graft failure. Invest Ophthalmol Vis Sci 2003; 44: 1837-1842.
12. Comer RM, King WJ, Ardjomand N, Theoharis S, George AJ, Larkin DF. Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival. Invest Ophthalmol Vis Sci 2002; 43: 1095-1103.
13. Gong N, Pleyer U, Yang J, Vogt K, Hill M, Anegon I et al. Influence of local and systemic CTLA4Ig gene transfer on corneal allograft survival. J Gene Med 2006; 8: 459-467.
14. Beutelspacher SC, Pillai R, Watson MP, Tan PH, Tsang J, McClure MO et al. Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur J Immunol 2006; 36: 690-700.
15. Lai YK, Shen WY, Brankov M, Lai CM, Constable IJ, Rakoczy PE. Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy. Gene Ther 2002; 9: 804-813.
16. Beutelspacher SC, Ardjomand N, Tan PH, Patton GS, Larkin DF, George AJ et al. Comparison of HIV-1 and EIAV-based lentiviral vectors in corneal transduction. Exp Eye Res 2005; 80: 787-794.
17. Fuller M, Anson DS. Helper plasmids for production of HIV-1 derived vectors. Hum Gene Ther 2002; 12: 2085-2097.
18. Anson DS, Fuller M. Rational development of a HIV-1 gene therapy vector. J Gene Med 2003; 5: 829-838.
19. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263-267.
20. Tuft SJ, Williams KA, Coster DJ. Endothelial repair in the rat cornea. Invest Ophthalmol Vis Sci 1986; 27: 1199-1204.
21. Liu JW, Pernod G, Dunoyer-Geindre S, Fish RJ, Yang H, Bounameaux H et al. Promoter dependence of transgene expression by lentivirus-transduced human blood-derived endothelial progenitor cells. Stem Cells 2006; 24: 199-208.
22. Kostic C, Chiodini F, Salmon P, Wiznerowicz M, Deglon N, Hornfeld D et al. Activity analysis of housekeeping promoters using self-inactivating lentiviral vector delivery into the mouse retina. Gene Ther 2003; 10: 818-821.
23. Pleyer U, Dannowski H. Delivery of genes via liposomes to corneal endothelial cells. Drug News Perspect 2002; 15: 283-289.
24. Jun AS, Larkin DFP. Prospects for gene therapy in corneal disease. Eye 2003; 17: 906-911.
25. Borras T. Recent developments in ocular gene therapy. Exp Eye Res 2003; 76: 643-652.
26. Klebe S, Sykes PJ, Coster DJ, Bloom DC, Williams KA. Gene transfer to ovine corneal endothelium. Clin Experiment Ophthalmol 2001; 29 316-322.
27. Larkin DF, Oral HB, Ring CJ, Lemoine NR, George AJ. Adenovirus-mediated gene delivery to the corneal endothelium. Transplantation 1996; 613: 363-370.
28. Somia N, Verma IM. Gene therapy: Trials and tribulations. Nat Rev Genet 2000; 1: 91-99.
29. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003; 4: 346-358.
30. Monahan PE, Samulski RJ. AAV vectors: Is clinical success on the horizon? Gene Ther 2000; 7: 24-30.
31. Buchschacher GL, Wong-Staal F. Development of lentiviral vectors for gene therapy for human diseases. Blood 2000; 95: 2499-2504.
32. Wang X, Appukuttan B, Ott S, Patel R, Irvine J, Song J et al. Efficient and sustained transgene expression in human corneal cells mediated by a lentiviral vector. Gene Ther 2000; 7: 196-200.
33. Takahashi K, Luo T, Saishin Y, Saishin Y, Sung J, Hackett S et al. Sustained transduction of ocular cells with a bovine immunodeficiency viral vector. Hum Gene Ther 2002; 13: 1305-1316.
34. Bainbridge JW, Stephens C, Parsley K, Demaison C, Halfyard A, Thrasher AJ et al. In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium. Gene Ther 2001; 8 1665-1668.
35. Igarashi T, Miyake K, Suzuki N, Takahashi H, Shimada T. New strategy for in vivo transgene expression in corneal epithelial progenitor cells. Curr Eye Res 2002; 24: 46-50.
36. Bennett J. Immune response following intraocular delivery of recombinant viral vectors. Gene Ther 2003; 10: 977-982.
37. Fuller M, Anson DS. Can the use of HIV-1 derived gene transfer vectors for clinical application be justified? Curr Gene Ther 2004; 4 65-77.
38. Montini E, Cesana D, Schmidt M, Sanvito F, Ponzoni M, Bartholomae C et al. Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol 2006; 24: 687-696.
39. Yanez-Munoz RJ, Balaggan KS, MacNeil A, Howe SJ, Schmidt M, Smith AJ et al. Effective gene therapy with nonintegrating lentiviral vectors. Nat Med 2006; 12: 348-353.
40. Limberis M, Anson DS, Fuller M, Parsons DW. Recovery of airway cystic fibrosis transmembrane conductance regulator function in mice with cystic fibrosis after single dose lentivirus-mediated gene transfer. Hum Gene Ther 2002; 13: 1961-1970.
41. Xu ZL, Mizuguchi H, Mayumi T, Hayakawa T. Woodchuck hepatitis virus post-transcriptional regulation element enhances transgene expression from adenovirus vectors. Biochim Biophys Acta 2003; 1621: 266-271.
42. Etiemble J, Degott C, Renard CA, Fourel G, Shamoon B, Vitvitski-Trepo L et al. Liver-specific expression and high oncogenic efficiency of a c-myc transgene activated by woodchuck hepatitis virus insertion. Oncogene 1994; 9: 727-737.
43. Fourel G, Couturier J, Wei Y, Apiou F, Tiollais P, Buendia MA. Evidence for long-range oncogene activation by hepadnavirus insertion. EMBO J 1994; 13: 2526-2534.
44. Kingsman SM, Mitrophanous K, Olsen JC. Potential oncogene activity of the woodchuck hepatitis post-transcriptional regulatory element (WPRE). Gene Ther 2005; 12: 3-4.
45. Koldej R, Cmielewski P, Stocker A, Parsons DW, Anson DS. Optimisation of a multipartite human immunodeficiency virus based vector system; control of virus infectivity and large-scale production. J Gene Med 2005; 7: 1390-1399.
46. Williams KA, Coster DJ. Penetrating corneal transplantation in the inbred rat: A new model. Invest Ophthalmol Vis Sci 1985; 26: 23-30.
47. Williams KA, Standfield SD, Mills RA, Takano T, Larkin DF, Krishnan R et al. A new model of orthotopic penetrating corneal transplantation in the sheep: Graft survival, phenotypes of infiltrating cells and local cytokine production. Aust NZ J Ophthalmol 1999; 27: 127-135.
48. Jessup CF, Brereton HM, Coster DJ, Williams KA. In vitro adenovirus-mediated gene transfer to the human cornea. Br J Ophthalmol 2005; 89: 658-661.